Liver hyperplasias & neooplasias Flashcards

1
Q

Solitary or multiple hyperplastic hepatocellular nodules that may develop in the non-cirrhotic Liver

A

Nodular hyperplasias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Causes of focal nodular hyperplasia

A

Long-term use of Anabolic Hormones or of Contraceptives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Epidemioology of focal nodular hyperplasia

A

Young to middle-aged adults

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Microscopic features of focal nodular hyperplasia

A
  • Large arterial vessels within central scar, showing fibromuscular hyperplasia & narrowing of their lumen
  • Foci of intense lymphocytic infiltrates within the radiating septa
  • Marked bile duct proliferation along septal margins
  • Normal appearing Hepatocytes in the parenchyma between the septa, but with a thickened plate architecture (typical for regeneration)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Macroscopic features of focal nodular hyperplasia

A
  • Well-demarcated but poorly encapsulated nodule
  • Lighter colouration than the surrounding Liver
  • Central gray-white, depressed stellate scar, with radiations to the periphery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Association with conditions affecting intra-hepatic blood flow

A

Nodular regenerative Hyperplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Macroscopic features of Nodular regenerative Hyperplasia

A

Entirely transformed Liver into roughly spherical nodules, in the absence of fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Microscopic features of Nodular regenerative Hyperplasia

A
  • Plump hepatocytes surrounded by rims of atrophic Hepatocytes (reticulin stain
  • Complications: Development of Portal Hypertension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Most common benign liver tumours

A

Cavernous Haemangiomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Localisation of Cavernous Haemangiomas

A

Directly beneath the capsule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Macroscopic features of Cavernous Haemangiomas

A

Size: <2cm in diameter – Discrete, red-blue, soft nodules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Microscopic features of Cavernous Haemangiomas

A

Vascular channels in a bed of fibrous connective tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is a hepatic adenoma?

A

A benign neoplasm of the liver.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the incidence of hepatic adenomas?

A

About 1 in 100,000 population.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which population is most commonly affected by hepatic adenomas?

A

Women using oral contraceptives.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What genetic mutations are associated with hepatic adenomas?

A

HNF1α mutations: Found in 50% of cases.
β-catenin mutations: Found in 15% of cases.

17
Q

Which syndrome is associated with HNF1 mutations?

A

Maturity-onset diabetes of the young (MODY3).

18
Q

Where are hepatic adenomas most often localized?

A

Beneath the liver capsule.

19
Q

Describe the macroscopic features of hepatic adenomas.

A

Size: Up to 30 cm in diameter.
Well-demarcated lesion.
Pale, yellow-tan, and frequently bile-stained.

20
Q

What are the major etiologic factors for hepatocellular carcinoma (HCC)?

A

Chronic viral infections (HBV, HCV).
Chronic alcoholism.
Nonalcoholic steatohepatitis (NASH).
Food contaminants (e.g., aflatoxins).
Hereditary tyrosinemia (HCC develops in ~40% of cases).

21
Q

How does HCC develop pathologically?

A

Originates from small-cell, high-grade dysplastic nodules in cirrhotic livers.
Dysplastic nodules are monoclonal with chromosomal aberrations similar to HCC.
Cells of origin: Mature hepatocytes and progenitor (ductular/oval) cells.
Characterized by genomic instability with structural and numeric chromosomal abnormalities.

22
Q

What are the macroscopic features of HCC?

A

Patterns:
Solitary large mass.
Multifocal nodules of variable size.
Diffusely infiltrative cancer.
Appearance: Paler than surrounding liver, sometimes green-hued.
Propensity for vascular invasion, leading to:
Extensive intrahepatic metastases.
Long snake-like masses in portal vein or inferior vena cava, occasionally extending into the heart.

23
Q

What are the histologic findings in HCC?

A

Tumour differentiation ranges from well-differentiated to anaplastic/undifferentiated.
Well and moderately differentiated forms:
Hepatocyte-like cells.
Arranged in trabecular, acinar, or pseudo-glandular patterns.
Poorly differentiated forms:
Pleomorphic tumour cells with anaplastic giant cells.
Small, undifferentiated cells.
Cells resembling spindle cell sarcoma

24
Q

What is fibrolamellar carcinoma?

A

A distinctive variant of hepatocellular carcinoma (HCC).

25
What is the aetiology of fibrolamellar carcinoma?
Unknown
26
What is the epidemiology of fibrolamellar carcinoma?
Accounts for 5% of HCCs. Occurs in young male and female adults (20-40 years). Equal incidence in males and females.
27
What are the macroscopic features of fibrolamellar carcinoma?
Single large, hard "scirrhous" tumour. Characterized by fibrous bands.
28
What are the microscopic findings in fibrolamellar carcinoma?
Well-differentiated polygonal cells with eosinophilic cytoplasm and prominent nucleoli. Tumour cells arranged in nests or cords, separated by parallel lamellae of dense collagen bundles.
29
How does fibrolamellar carcinoma progress?
Within the liver: Widespread extension via contiguous growth and satellite nodules. Extra-hepatic metastases: Vascular invasion into the hepatic vein system. Late haematogenous metastases (primarily to the lungs). Lymph node metastases (<50% of cases) to peri-hilar, peripancreatic, and para-aortic nodes.
30
What are the clinical manifestations of fibrolamellar carcinoma?
Ill-defined upper abdominal pain. Malaise and fatigue. Weight loss. Abdominal mass or fullness (occasionally).
31
What might be found on physical examination in fibrolamellar carcinoma?
Enlarged, palpable liver with irregularity or nodularity.
32
What laboratory findings are associated with fibrolamellar carcinoma?
Elevated serum α-fetoprotein (AFP) in advanced tumours (50% of cases). Immunostaining for Glypican-3 helps distinguish early HCC from dysplastic nodules. False-positive AFP results in yolk-sac tumours, cirrhosis, chronic hepatitis, and normal pregnancy.
33
What imaging studies are most valuable for detecting fibrolamellar carcinoma?
Ultrasonography, hepatic angiography, CT, and MRI.
34
How is fibrolamellar carcinoma managed?
Resection or ablation for a single small lesion (curative for fibrolamellar variant). Liver transplantation. Sorafenib for advanced disease. Without resection: Median survival is seven months.